Eliem Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%)等
04/12 18:53 (美東)
Eliem Therapeutics | DEFA14A:其他
04/11 08:14 (美東)
Eliem Therapeutics | 8-K:重大事件
04/11 08:04 (美東)
Eliem Therapeutics | 4:持股變動聲明-高管 Morisset Valerie
04/08 17:38 (美東)
Eliem Therapeutics | S-8:員工福利計劃證券登記
03/28 16:35 (美東)
Eliem Therapeutics | 10-K:年度報表
03/28 16:10 (美東)
Eliem Therapeutics | 4:持股變動聲明-高管 Pimblett Emily
03/20 16:38 (美東)
Eliem Therapeutics | 8-K:重大事件
03/19 13:33 (美東)
Eliem Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%)等
03/18 16:51 (美東)
Eliem Therapeutics | 4:持股變動聲明-高管 Morisset Valerie
03/04 11:10 (美東)
Eliem Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Braden M Leonard(8.5%),BML Investment Partners, L.P.(7.9%)
02/07 11:56 (美東)
Eliem Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(47.7%),Peter Kolchinsky(47.7%)等
2023/11/17 16:30 (美東)
Eliem Therapeutics:2023財年三季報
2023/11/14 16:01 (美東)
Eliem Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)
2023/11/13 17:13 (美東)
Eliem Therapeutics | 10-Q:2023財年二季報
2023/08/10 16:06 (美東)
Eliem Therapeutics | 8-K:重大事件
2023/07/20 06:55 (美東)
Eliem Therapeutics | 4:持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.
2023/05/22 17:22 (美東)
Eliem Therapeutics | 4:持股變動聲明-董事 Tate Simon
2023/05/22 17:13 (美東)
Eliem Therapeutics | 4:持股變動聲明-董事 Ratcliffe Liam
2023/05/22 17:11 (美東)
Eliem Therapeutics | 4:持股變動聲明-董事 Dunn Judith
2023/05/22 17:08 (美東)
暫無數據
暫無數據